TFX

+ Watchlist + Portfolio

Teleflex Inc.

Regulated industry Physical products Sells to businessesTags from an AI model reading the company description.

GridBrain — Sign in

GridSentinel — Sign in

GridAegis — Sign in

Key Metrics

Previous Close: $126.11
52-Week Range: $100.18 – $145.00
Market Cap: $5.26B
P/E (TTM): —
EPS (TTM): -8.48
Dividend Yield: 1.10%

Advanced Metrics

Price/Book: 1.81
PEG Ratio: 0.16
Return on Equity: -0.70%
Return on Assets: 1.75%
Gross Margin: 55.11%
Operating Margin: 10.06%
Profit Margin: -45.76%
Current Ratio: 2.60
Debt/Equity: 1.01
Total Debt: $2.94B
Free Cash Flow: $179.54M
Revenue Growth: 28.90%
Earnings Growth: -17.30%
Enterprise Value: $7.87B

TFX Income statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Revenue	$2.79B	$1.71B	$1.70B	$1.99B
Cost of Revenue	$1.26B	$672.33M	$662.16M	$871.96M
Gross Profit	$1.53B	$1.04B	$1.04B	$1.12B
Research & Development	$153.82M	$113.63M	$109.02M	$144.78M
Selling, General & Admin	$863.75M	$622.74M	$674.52M	$720.17M
Operating Expenses	$1.02B	$736.37M	$783.54M	$864.95M
Operating Income	$513.52M	$303.75M	$253.85M	$255.80M
EBITDA	$730.77M	$418.51M	$271.34M	$302.51M
Pretax Income	$445.92M	$185.39M	$26.29M	$24.55M
Income Tax	$83.00M	$41.87M	-$30.90M	-$33.98M
Net Income	$363.14M	$356.33M	$69.67M	-$905.64M
Diluted EPS	7.68	7.53	1.48	-20.30
Diluted Shares	47.31M	47.30M	47.09M	44.72M

TFX Balance Sheet statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Cash & Equivalents	$292.03M	$222.85M	$247.85M	$378.56M
Receivables	$408.83M	$443.47M	$226.73M	$345.58M
Inventory	$578.51M	$626.22M	$306.77M	$404.39M
Current Assets	$1.41B	$1.41B	$1.47B	$1.94B
Total Assets	$6.93B	$7.53B	$7.10B	$6.95B
Current Liabilities	$581.49M	$606.75M	$649.36M	$762.03M
Long-Term Debt	$1.62B	$1.73B	$1.56B	$2.54B
Total Debt	$1.83B	$1.93B	$1.74B	$2.73B
Total Liabilities	$2.91B	$3.09B	$2.82B	$3.82B
Retained Earnings	$3.82B	$4.11B	$4.12B	$3.15B
Shareholders' Equity	$4.02B	$4.44B	$4.28B	$3.12B
Working Capital	$829.49M	$800.66M	$821.76M	$1.18B
Net Debt	$1.42B	$1.59B	$1.41B	$2.26B

TFX Cash Flow statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Operating Cash Flow	$342.14M	$510.64M	$635.74M	$340.68M
Capital Expenditure	-$79.19M	-$46.42M	-$90.44M	-$95.24M
Free Cash Flow	$262.95M	$464.22M	$545.30M	$245.44M
Depreciation & Amortisation	$230.59M	$148.10M	$161.53M	$177.74M
Stock-Based Compensation	$27.22M	$27.30M	$25.96M	$25.70M
Investing Cash Flow	-$257.94M	-$621.23M	-$99.36M	-$849.19M
Financing Cash Flow	-$217.51M	$38.54M	-$421.93M	$611.54M
Dividends Paid	-$63.79M	-$63.90M	-$63.54M	-$60.27M
Share Repurchases	$0.00	$0.00	-$200.00M	-$300.00M
Net Change in Cash	-$133.31M	-$72.05M	$114.45M	$103.03M

TFX Income statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Revenue	$414.26M	$442.52M	$913.02M	-$401.87M	$548.26M	$570.33M
Cost of Revenue	$158.83M	$176.69M	$461.38M	-$250.45M	$240.84M	$238.63M
Gross Profit	$255.43M	$265.83M	$451.64M	-$151.41M	$307.43M	$331.71M
Research & Development	$25.30M	$26.49M	$57.23M	$12.63M	$44.39M	$45.12M
Selling, General & Admin	$152.91M	$137.50M	$281.76M	$614.00K	$226.01M	$213.51M
Operating Expenses	$178.21M	$163.99M	$338.99M	$13.24M	$270.40M	$258.64M
Operating Income	$77.22M	$101.84M	$112.65M	-$164.65M	$37.03M	$73.07M
EBITDA	$115.91M	$129.25M	-$271.27M	$247.07M	$75.63M	$122.91M
Pretax Income	$58.75M	$70.66M	-$438.58M	$218.94M	-$3.83M	$45.14M
Income Tax	$6.42M	$2.49M	-$29.70M	-$30.78M	$1.01M	$3.38M
Net Income	$95.00M	$122.58M	-$408.89M	-$714.33M	-$8.15M	$99.69M
Diluted EPS	2.07	2.77	-9.24	-16.15	-0.18	2.28
Diluted Shares	45.93M	44.33M	44.24M	44.24M	44.26M	43.66M

TFX Balance Sheet statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Cash & Equivalents	$284.12M	$253.70M	$354.00M	$378.56M	$309.41M	$300.16M
Receivables	$464.52M	$513.81M	$592.65M	$345.58M	$365.53M	$364.61M
Inventory	$643.97M	$693.69M	$802.47M	$404.39M	$380.86M	$351.91M
Current Assets	$1.54B	$1.72B	$1.99B	$1.94B	$1.86B	$1.88B
Total Assets	$7.16B	$7.38B	$7.87B	$6.95B	$6.78B	$6.79B
Current Liabilities	$675.91M	$716.15M	$773.03M	$762.03M	$728.05M	$720.38M
Long-Term Debt	$1.81B	$1.80B	$2.57B	$2.54B	$2.51B	$2.72B
Total Debt	$2.00B	$2.00B	$2.77B	$2.73B	$2.69B	$2.87B
Total Liabilities	$3.07B	$3.13B	$4.05B	$3.82B	$3.70B	$3.88B
Retained Earnings	$4.20B	$4.30B	$3.88B	$3.15B	$3.13B	$3.21B
Shareholders' Equity	$4.10B	$4.24B	$3.82B	$3.12B	$3.08B	$2.90B
Working Capital	$863.00M	$1.01B	$1.21B	$1.18B	$1.13B	$1.16B
Net Debt	$1.62B	$1.65B	$2.32B	$2.26B	$2.31B	$2.51B

TFX Cash Flow statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Operating Cash Flow	$73.09M	$7.74M	$107.64M	$152.21M	$49.02M	$94.33M
Capital Expenditure	-$24.13M	-$27.79M	-$42.66M	-$651.00K	-$18.79M	-$14.03M
Free Cash Flow	$48.96M	-$20.05M	$64.97M	$151.56M	$30.23M	$80.30M
Depreciation & Amortisation	$38.62M	$36.89M	$135.46M	-$33.23M	$53.74M	$49.82M
Stock-Based Compensation	$6.63M	$5.66M	$10.51M	$2.90M	$6.74M	$5.44M
Investing Cash Flow	-$28.79M	-$30.49M	-$767.50M	-$22.41M	-$84.00M	-$15.51M
Financing Cash Flow	-$59.52M	-$23.67M	$756.34M	-$61.61M	-$44.98M	-$82.00M
Dividends Paid	-$15.19M	-$15.03M	-$15.02M	-$15.03M	-$15.05M	-$14.78M
Share Repurchases	-$300.00M	-$1.89M	$0.00	$0.00	$0.00	-$250.00M
Net Change in Cash	-$15.22M	-$46.41M	$96.47M	$68.19M	-$79.96M	-$3.18M

Market Snapshot

About

Teleflex is a global provider of medical technologies designed to improve the health and quality of patient care. The company manufactures and distributes single-use medical devices for critical care, surgical applications, interventional cardiology, and urology, serving hospitals and healthcare providers worldwide.